Aclaris Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2018
Total Assets: $275.6M
Liabilities Breakdown FY2018
Total Liabilities: $60.4M
Asset Breakdown
Total Assets: $275.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $57.0M | 20.7% |
| Accounts Receivable | $563.0K | 0.2% |
| Inventory | $791.0K | 0.3% |
| Property, Plant & Equipment | $2.3M | 0.8% |
| Goodwill | $18.5M | 6.7% |
| Intangible Assets | $7.3M | 2.6% |
| Other Assets | $189.1M | 68.6% |
Liabilities Breakdown
Total Liabilities: $60.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $11.7M | 19.3% |
| Long-Term Debt | $29.9M | 49.5% |
| Other Liabilities | $18.9M | 31.2% |